Atezolizumab
ML40560
Phase 2 small_molecule active
Quick answer
Atezolizumab for NSCLC Stage IIIB is a Phase 2 program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- NSCLC Stage IIIB
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active